EUR 13.8
(-1.43%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 149.83 Million EUR | -5.29% |
2022 | 158.2 Million EUR | -0.98% |
2021 | 159.76 Million EUR | -0.52% |
2020 | 160.6 Million EUR | -6.73% |
2019 | 172.2 Million EUR | 63.22% |
2018 | 105.5 Million EUR | 2605.13% |
2017 | 3.9 Million EUR | -71.94% |
2016 | 13.9 Million EUR | -91.43% |
2015 | 162.2 Million EUR | 1.82% |
2014 | 159.3 Million EUR | -80.38% |
2013 | 811.8 Million EUR | -21.84% |
2012 | 1.03 Billion EUR | 0.0% |
2011 | - EUR | 0.0% |
2010 | - EUR | 0.0% |
2009 | - EUR | -100.0% |
2008 | 729.39 Million EUR | 0.0% |
2007 | - EUR | 0.0% |
2006 | - EUR | 0.0% |
2005 | - EUR | 0.0% |
2004 | - EUR | -100.0% |
2003 | 179.76 Million EUR | -17.91% |
2002 | 218.98 Million EUR | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 143.45 Million EUR | -4.26% |
2024 Q2 | 150.86 Million EUR | 5.17% |
2023 Q4 | 149.83 Million EUR | -0.39% |
2023 Q3 | 150.42 Million EUR | 1734.49% |
2023 Q2 | 8.2 Million EUR | -94.55% |
2023 Q1 | 150.36 Million EUR | -4.95% |
2023 FY | 149.83 Million EUR | -5.29% |
2022 Q2 | 157.3 Million EUR | 4.63% |
2022 Q4 | 158.2 Million EUR | 5.15% |
2022 Q3 | 150.45 Million EUR | -4.35% |
2022 Q1 | 150.34 Million EUR | -5.9% |
2022 FY | 158.2 Million EUR | -0.98% |
2021 Q2 | 10.2 Million EUR | -93.21% |
2021 FY | 159.76 Million EUR | -0.52% |
2021 Q4 | 159.76 Million EUR | 6.34% |
2021 Q1 | 150.11 Million EUR | -6.53% |
2021 Q3 | 150.23 Million EUR | 1372.88% |
2020 Q2 | 160.81 Million EUR | 0.5% |
2020 Q1 | 160.01 Million EUR | -7.08% |
2020 Q3 | 11.5 Million EUR | -92.85% |
2020 Q4 | 160.6 Million EUR | 1296.55% |
2020 FY | 160.6 Million EUR | -6.73% |
2019 Q1 | 100.23 Million EUR | -4.99% |
2019 FY | 172.2 Million EUR | 63.22% |
2019 Q2 | 100.64 Million EUR | 0.41% |
2019 Q3 | 13 Million EUR | -87.08% |
2019 Q4 | 172.2 Million EUR | 1224.62% |
2018 Q3 | 2.8 Million EUR | -6.67% |
2018 Q4 | 105.5 Million EUR | 3667.86% |
2018 FY | 105.5 Million EUR | 2605.13% |
2018 Q1 | 2.7 Million EUR | -30.77% |
2018 Q2 | 3 Million EUR | 11.11% |
2017 Q4 | 3.9 Million EUR | 25.81% |
2017 FY | 3.9 Million EUR | -71.94% |
2017 Q1 | 10 Million EUR | -28.06% |
2017 Q3 | 3.1 Million EUR | -69.19% |
2017 Q2 | 10.06 Million EUR | 0.63% |
2016 FY | 13.9 Million EUR | -91.43% |
2016 Q1 | 10 Million EUR | -93.83% |
2016 Q4 | 13.9 Million EUR | 39.0% |
2016 Q2 | 10 Million EUR | 0.01% |
2016 Q3 | 10 Million EUR | -0.01% |
2015 FY | 162.2 Million EUR | 1.82% |
2015 Q4 | 162.2 Million EUR | 3.86% |
2015 Q3 | 156.16 Million EUR | 0.94% |
2015 Q2 | 154.7 Million EUR | 0.94% |
2015 Q1 | 153.26 Million EUR | -3.79% |
2014 Q2 | 164.21 Million EUR | -59.91% |
2014 Q3 | 155.92 Million EUR | -5.05% |
2014 Q1 | 409.56 Million EUR | -49.55% |
2014 Q4 | 159.3 Million EUR | 2.17% |
2014 FY | 159.3 Million EUR | -80.38% |
2013 Q2 | 907.36 Million EUR | -9.18% |
2013 FY | 811.8 Million EUR | -21.84% |
2013 Q1 | 999.07 Million EUR | -3.81% |
2013 Q4 | 811.8 Million EUR | 2.43% |
2013 Q3 | 792.51 Million EUR | -12.66% |
2012 Q2 | - EUR | 0.0% |
2012 Q3 | - EUR | 0.0% |
2012 Q4 | 1.03 Billion EUR | 0.0% |
2012 FY | 1.03 Billion EUR | 0.0% |
2012 Q1 | - EUR | -100.0% |
2011 Q3 | - EUR | 0.0% |
2011 Q4 | 1.02 Billion EUR | 0.0% |
2011 FY | - EUR | 0.0% |
2011 Q1 | - EUR | 0.0% |
2011 Q2 | - EUR | 0.0% |
2010 Q4 | - EUR | 0.0% |
2010 FY | - EUR | 0.0% |
2010 Q1 | - EUR | 0.0% |
2010 Q3 | - EUR | 0.0% |
2010 Q2 | - EUR | 0.0% |
2009 Q4 | - EUR | 0.0% |
2009 FY | - EUR | -100.0% |
2008 FY | 729.39 Million EUR | 0.0% |
2007 FY | - EUR | 0.0% |
2006 FY | - EUR | 0.0% |
2005 FY | - EUR | 0.0% |
2004 FY | - EUR | -100.0% |
2003 FY | 179.76 Million EUR | -17.91% |
2002 FY | 218.98 Million EUR | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Fresenius Medical Care AG & Co. KGaA | 12.05 Billion EUR | 98.757% |
Fresenius SE & Co. KGaA | 15.83 Billion EUR | 99.053% |
LIMES Schlosskliniken AG | 10.09 Million EUR | -1384.999% |
M1 Kliniken AG | 17.04 Million EUR | -779.106% |
Maternus-Kliniken Aktiengesellschaft | 112.35 Million EUR | -33.366% |
MEDICLIN Aktiengesellschaft | 479.82 Million EUR | 68.773% |
VITA 34 AG | 21.57 Million EUR | -594.494% |